网站综合信息 epivax.org
- 标题:
- EpiVax, Inc. – Informatics and I
- 关键字:
- 描述:
- 域名信息
- 域名年龄:18年3天 注册日期:2007年12月07日 到期时间:2015年12月07日
邮箱:epivax 电话:+1.401952325
注册商:Network Solutions, LLC (R63-LROR)
- 服务器空间
- IP:173.255.198.191 同IP网站3个 详情
地址:美国 新泽西州Linode公司
- 备案信息
- 备案号:
域名流量Alexa排名
域名注册Whois信息
epivax.org
域名年龄: 18年3天注册时间: 2007-12-07
到期时间: 2015-12-07
注 册 商: Network Solutions, LLC (R63-LROR)
注册邮箱: epivax
联系电话: +1.401952325
获取时间: 2013年11月24日 22:02:31
Access to .ORG WHOIS information is provided to assist persons in
determining the contents of a domain name registration record in the
Public Interest Registry registry database. The data in this record is provided by
Public Interest Registry for informational purposes only, and Public Interest Registry does not
guarantee its accuracy. This service is intended only for query-based
access. You agree that you will use this data only for lawful purposes
and that, under no circumstances will you use this data to: (a) allow,
enable, or otherwise support the transmission by e-mail, telephone, or
facsimile of mass unsolicited, commercial advertising or solicitations
to entities other than the data recipient's own existing customers; or
(b) enable high volume, automated, electronic processes that send
queries or data to the systems of Registry Operator, a Registrar, or
Afilias except as reasonably necessary to register domain names or
modify existing registrations. All rights reserved. Public Interest Registry reserves
the right to modify these terms at any time. By submitting this query,
you agree to abide by this policy.
Domain ID:D150233458-LROR
Domain Name:EPIVAX.ORG
Created On:2007-Dec-06 22:22:18 UTC
Last Updated On:2012-Oct-07 07:40:30 UTC
Expiration Date:2015-Dec-06 22:22:18 UTC
Sponsoring Registrar:Network Solutions, LLC (R63-LROR)
Status:CLIENT TRANSFER PROHIBITED
Registrant ID:30460335-NSI
Registrant Name:Epivax, Inc.
Registrant Organization:Epivax, Inc.
Registrant Street1:146 Clifford Street
Registrant Street2:
Registrant Street3:
Registrant City:Providence
Registrant State/Province:RI
Registrant Postal Code:02903
Registrant Country:US
Registrant Phone:+1.401952325
Registrant Phone Ext.:
Registrant FAX:+1.999999999
Registrant FAX Ext.:
Registrant Email:epivax
Admin ID:30460336-NSI
Admin Name:Bill Martin
Admin Organization:Epivax Inc.
Admin Street1:146 Clifford Street
Admin Street2:
Admin Street3:
Admin City:Providence
Admin State/Province:RI
Admin Postal Code:02903
Admin Country:US
Admin Phone:+1.4019523259
Admin Phone Ext.:
Admin FAX:+1.4012727562
Admin FAX Ext.:
Admin Email:martinb
Tech ID:30460336-NSI
Tech Name:Bill Martin
Tech Organization:Epivax Inc.
Tech Street1:146 Clifford Street
Tech Street2:
Tech Street3:
Tech City:Providence
Tech State/Province:RI
Tech Postal Code:02903
Tech Country:US
Tech Phone:+1.4019523259
Tech Phone Ext.:
Tech FAX:+1.4012727562
Tech FAX Ext.:
Tech Email:martinb
Name Server:NS79.WORLDNIC.COM
Name Server:NS80.WORLDNIC.COM
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
DNSSEC:Unsigned
网站头文件(HTTP Header)
HTTP/1.1 301 永久重定向 服务器:WP Engine/1.2.0 访问时间:2012年10月18日 07:53:11 类型:text/html 文件大小:188 连接:keep-alive Keep-Alive: timeout=20 目标网址:http://www.epivax.com/ HTTP/1.1 200 OK 服务器:WP Engine/1.2.0 访问时间:2012年10月18日 07:53:11 类型:text/html; charset=UTF-8 Transfer-Encoding: chunked 连接:keep-alive Keep-Alive: timeout=20 X-Pingback: http://www.epivax.com/xmlrpc.php X-Cacheable: SHORT 动作:Accept-Encoding,Cookie 缓存控制:max-age=600,必须更新 缓存代理:HIT: 3 X-Cache-Group: normal X-Type: default 网站编码:UTF-8
同IP网站(同服务器)
其他后缀域名
网站首页快照(纯文字版)
抓取时间:2012年10月18日 07:52:26
网址:http://epivax.org/
标题:EpiVax, Inc. – Informatics and Immunology | Making the
关键字:
描述:
主体:
网址:http://epivax.org/
标题:EpiVax, Inc. – Informatics and Immunology | Making the
关键字:
描述:
主体:
Search for: Skip to content Immunogenicity Screening EpiMatrix PreDeFT ISPRI Web-based Immunogenicity Screening Validating Technologies Frequently Asked Questions (FAQ) Immunogenicity Testing HLA Transgenic Mice In Silico Screening: EpiMatrix In Silico Screening: Tregitopes In Vitro Screening – T Cell Assays Vaccine Design & Redesign The EpiVax Approach Genome to Vaccine iVAX Web-based Vaccine Design Protein Engineering DeFT Including How Tregitope Can Be Used in a DeFT Project Modification of Proteins for Reduced Immunogenicity Pipeline Immune Modulation Deimmunization BioDefense Vaccines Home Improving human health everywhere. SCIENCE WITHOUT FEAR Scientists at EpiVax are expert practitioners of a new discipline- immunoinformatics. We have harnessed the power of immune modulation for the development of improved vaccines and biotherapeutics. We take pride in our creativity and our ability to put our combined intelligence, experience, and creativity to work to improve human health. Open minds, creative thought and natural curiosity lead to paradigm shifts. Services Pipeline Corporate Responsibility Immunogenicity Screening Immunogenicity Testing Protein Engineering Vaccine Design & Redesign Immune Modulation – Tregitope Tregitope Applications Deimmunization BioDefense Vaccines EpiVax is dedicated to supporting a number of local and global causes. Comments are closed. CONTACT EpiVax, Inc. 146 Clifford St. Providence, RI 02903 (Email EpiVax) Dr. Timothy Messitt, Ph.D. Manager Business Development ph: 401.272.2123 fax: 401.272.7562 tmessitt@epivax.com Curtis Miller Associate Business Development ph: 401.272.2123 fax: 401.272.7562 cmilleriv@epivax.com Home About Us Blog Press Corporate Responsibility Collaborators Links Contact Events BLOGBiowarfare Experts Speak in Providence Summiting on Immunogenicity and Epitope Networks More Pesky Anti-Drug-Antibodies, now from Novo Nordisk Panacea or Placebo: IVIg for Alzheimers? Who would want “vaccines on demand”? Ask the mother of a child in Cambodia. Of (Hamsters) and Men: Host Cell Protein Immunogenicity – What does it mean? The "I" in Bio: From Bamako to Providence Happy Birthday Up Start Biotech! EpiVax Turns 14! PRESSBiowarfare Experts Speak in Providence Summiting on Immunogenicity and Epitope Networks Hands On Vaccine Design in Yokohama Tregitope World Tour Fall 2012 EpiVax Awarded SBIR Phase II for Further Proof of Principle Studies There must be something "there" there: Tregitopes and FVIII EpiVax to attend ICIW 2012 The "I" in Bio [technology]: Tell us your story © 2010 EpiVax, Inc. – Informatics and Immunology, All rights reserved. • 146 Clifford St., Providence, RI 02903 • ph: 401.272.2123 • fax: 401.272.7562
最近查询网站